What happens when you stop taking Mounjaro?
When you stop tirzepatide, appetite and food noise return within days to weeks as the drug clears, and some weight regain is common — but it is not automatic. In the largest withdrawal trial, people who came off after 36 weeks of treatment gave back much of the loss but were still 9.9% below their starting weight a year later. How you stop changes what happens next.
Last updated: 30 August 2026
How quickly does it leave your system?
Tirzepatide has a half-life of about five days, so it takes roughly four to five weeks for the medication to fully clear. You will usually notice the appetite change long before that — most people describe hunger and food noise creeping back in the first one to three weeks after the last injection, as blood levels fall below the level that was suppressing appetite.
The physical side effects tend to fade in the same window: nausea, early fullness and slowed stomach emptying settle, and normal digestion returns.
What actually comes back — and in what order
Timeframe after last dose | What most people notice
Days 3–10 | Stomach empties normally again; larger portions feel possible; nausea eases
Weeks 1–3 | Appetite returns; food noise gets louder; snacking urges reappear
Weeks 3–6 | Body recalibrates; hunger is high but starts to find a rhythm
Month 2 onwards | Appetite settles nearer to your own baseline — this is where habits and structure decide the trajectory
This is physiology, not willpower. GLP-1 medication supplies a version of a hormone your body already makes — but at a much higher and steadier level than your gut ever produces on its own. Your own GLP-1 comes in short bursts after meals and is broken down within minutes. When the medication clears, that large steady signal goes with it and what remains is your own, smaller one. Nothing has been damaged; the scaffolding has been taken away.
Will the weight come back?
Not necessarily, and the honest answer is that the evidence points in two directions. In the trials: in the STEP 1 extension, people who stopped semaglutide regained about two-thirds of the weight they had lost within a year — but a year after stopping, they were still 5.6% below their starting weight (Wilding et al., Diabetes, Obesity and Metabolism, 2022). In SURMOUNT-4, people who switched from tirzepatide to placebo regained 14.0% of body weight over 52 weeks — and still ended at 9.9% below where they started (JAMA, 2024).
In the real world, the picture is milder. An analysis of more than 20,000 patients who stopped semaglutide found that 56% maintained their weight loss or continued losing a year later, and that the picture was largely stable at two years (Epic Research, 2024). Two things explain the gap. Both trials withdrew the medication and the support programme on the same day, by design; real life rarely does. And trial participants are, on average, heavier than the typical private patient in the UK.
The useful conclusion is not “you will regain two-thirds”. It is: regain isn’t guaranteed, and the way you stop changes what happens next.
Why does the regain feel so fast?
Three things happen at once, which is why it can feel like everything unravels in a fortnight:
1. Appetite returns before confidence does. You are suddenly making dozens of food decisions a day that the medication was quietly making for you.
2. Portion capacity returns. Your stomach empties at normal speed again, so the meal that filled you in June doesn’t in September.
3. Some of the weight lost was muscle. Less than the usual headlines suggest — measured directly, women lose roughly 1–1.5 kg of skeletal muscle per 10 kg of weight lost without resistance training. But muscle is the tissue that burns glucose and holds your metabolic rate up, so even that much makes maintaining harder. The numbers are unpicked here: how much muscle do you lose on weight-loss jabs?
Add the first few pounds back, and the scale confirms a fear you already had. That’s the moment most people describe as the hardest — and it is a psychological problem as much as a physiological one.
What can you do about it?
The four things with the strongest evidence behind them, in the order they matter:
• Protein, deliberately. Roughly 1.2–1.6 g per kg of body weight per day, spread across meals rather than loaded into dinner. This is the single best-supported lever for holding onto muscle during and after weight loss.
• Resistance training twice a week. The best-supported way to hold onto lean tissue while losing weight — and it works just as well after stopping.
• A meal rhythm you don’t have to think about. Regular, protein-anchored meals stabilise blood sugar and reduce the size of the appetite swings. Chaotic eating amplifies them.
• Fibre and gut health. Soluble, fermentable fibre is one of the routes by which your own GLP-1 gets released — see Can your body make its own GLP-1?
Should you stop suddenly or taper?
That decision belongs to you and your prescriber, and there is no universal protocol. What is increasingly discussed in 2026 is structured “off-ramping” — stepping the dose down over weeks rather than stopping outright — and the option of a low maintenance dose instead of all-or-nothing. Both are legitimate. Neither is a failure.
The practical case for a gradual reduction is that appetite returns in stages rather than all at once, which gives you time to build the structure that has to hold afterwards. More detail: How to taper off a GLP-1 safely.
When should you speak to a doctor?
Talk to your prescriber before you stop, not after — particularly if you take medication for type 2 diabetes, blood pressure or cholesterol. Weight change affects those prescriptions, and doses set at your lowest weight may need reviewing. In the UK, NICE quality standard QS212 states that people stopping weight-management medication should receive advice and support to maintain the changes they have made — including well-rehearsed “if–then” action plans, monitoring at regular intervals for at least a year, and the social support needed to keep those changes going.
If you are paying privately, ask specifically what happens after your last prescription. Many providers do not offer this, and it is better to find that out in advance.
Sources
• Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022. PubMed
• Aronne LJ et al. Continued treatment with tirzepatide for maintenance of weight reduction: the SURMOUNT-4 randomized clinical trial. JAMA, 2024; 331(1): 38–48. PubMed
• Epic Research. Many patients maintain weight loss a year after stopping semaglutide and liraglutide, 2024. Link
• Fundamental body composition principles provide context for fat-free and skeletal muscle loss with GLP-1 RA treatments. Journal of the Endocrine Society, 2024 (reports the STEP 1 DXA substudy figures). PMC
• Look M et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study. Diabetes, Obesity and Metabolism, 2025. Link
• NICE. Overweight and obesity management, Quality Standard QS212, statement 7 (2025). Link
This page is general information about nutrition and lifestyle. It is not medical advice, and it is not a substitute for the advice of your doctor or prescriber. Any decision about starting, changing or stopping medication is one for you and your prescriber.
PS NOW is an independent eight-week programme for women coming off GLP-1 medication — no prescriptions, no medication sales, no commission.
See how it works.